Literature DB >> 9048927

Human hepatocyte nuclear factor-4 (hHNF-4) gene maps to 20q12-q13.1 between PLCG1 and D20S17.

A Argyrokastritis1, S Kamakari, M Kapsetaki, A Kritis, I Talianidis, N K Moschonas.   

Abstract

Human hepatocyte nuclear factor 4 (hHNF-4) is a member of the nuclear hormone receptor superfamily and an important transcription factor and developmental regulator of liver-specific genes. Distinct hHNF-4 cDNAs corresponding to various HNF-4 isoforms have been recently characterised. Three cDNAs, hHNF-4A, B and C, are considered splice variants of a single hHNF-4 gene. We have mapped hHNF-4 to 20q12-q13.1 between PLCG1 and D20S17 by genetic linkage analysis, taking advantage of an adjacent PstI restriction fragment length polymorphism, (RFLP), and by fluorescence in situ hybridisation. hHFN-4 maps to chromosome 20 in a region syntenic with mouse chromosome 2 where the hnf-4 homologue has been assigned.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9048927     DOI: 10.1007/s004390050345

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  3 in total

1.  Prediabetes is associated with HNF-4 α P2 promoter polymorphism rs1884613: a case-control study in Han Chinese population and an updated meta-analysis.

Authors:  Changyi Wang; Sihan Chen; Tao Zhang; Zhongwei Chen; Shengyuan Liu; Xiaolin Peng; Jianping Ma; Xiaohong Zhong; Yanqiong Yan; Linlin Tang; Yifeng Mai; Liyuan Han; Shiwei Duan
Journal:  Dis Markers       Date:  2014-10-15       Impact factor: 3.434

2.  Association Analysis of the HNF4A Common Genetic Variants with Type 2 Diabetes Mellitus Risk.

Authors:  Seyedeh Mina Azizi; Negar Sarhangi; Mahdi Afshari; Davood Abbasi; Hamid Reza Aghaei Meybodi; Mandana Hasanzad
Journal:  Int J Mol Cell Med       Date:  2019-08-28

3.  Candidate gene association study in type 2 diabetes indicates a role for genes involved in beta-cell function as well as insulin action.

Authors:  Inês Barroso; Jian'an Luan; Rita P S Middelberg; Anne-Helen Harding; Paul W Franks; Rupert W Jakes; D Clayton; Alan J Schafer; Stephen O'Rahilly; Nicholas J Wareham
Journal:  PLoS Biol       Date:  2003-10-13       Impact factor: 8.029

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.